Literature DB >> 8634434

Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites.

M Introna1, V V Alles, M Castellano, G Picardi, L De Gioia, B Bottazzai, G Peri, F Breviario, M Salmona, L De Gregorio, T A Dragani, N Srinivasan, T L Blundell, T A Hamilton, A Mantovani.   

Abstract

Pentraxins, which include C reactive protein (CRP) and serum amyloid P component (SAP), are prototypic acute phase reactants that serve as indicators of inflammatory reactions. Here we report genomic and cDNA cloning of mouse ptx3 (mptx3), a member of the pentraxin gene family and characterize its extrahepatic expression in vitro and in vivo. mptx3 is organized into three exons on chromosome 3: the first (43 aa) and second exon (175 aa) code for the signal peptide and for a protein portion with no high similarity to known sequences the third (203 aa) for a domain related to classical pentraxins, which contains the "pentraxin family signature." Analysis of the N terminal portion predicts a predominantly alpha helical structure, while the pentraxin domain of ptx3 is accommodated comfortably in the tertiary structure fold of SAP. Normal and transformed fibroblasts, undifferentiated and differentiated myoblasts, normal endothelial cells, and mononuclear phagocytes express mptx3 mRNA and release the protein in vitro on exposure to interleukin-1beta (IL-1beta) and tumor necrosis factor (TNF)alpha. mptx3 was induced by bacterial lipopolysaccharide in vivo in a variety of organs and, most strongly, in the vascular endothelium of skeletal muscle and heart. Thus, mptx3 shows a distinct pattern of in vivo expression indicative of a significant role in cardiovascular and inflammatory pathology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634434

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  65 in total

1.  Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA).

Authors:  M M Luchetti; G Piccinini; A Mantovani; G Peri; C Matteucci; G Pomponio; M Fratini; P Fraticelli; P Sambo; C Di Loreto; A Doni; M Introna; A Gabrielli
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

Review 2.  Therapeutic inhibition of angiogenesis.

Authors:  Hua-Tang Zhang; Roy Bicknell
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

3.  Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm.

Authors:  Elisa R Zanier; Giovanna Brandi; Giuseppe Peri; Luca Longhi; Tommaso Zoerle; Mauro Tettamanti; Cecilia Garlanda; Anna Sigurtà; Serenella Valaperta; Alberto Mantovani; Maria Grazia De Simoni; Nino Stocchetti
Journal:  Intensive Care Med       Date:  2010-11-12       Impact factor: 17.440

4.  Pentraxin 3: A Biomarker Link between Inflammation and Cardiovascular Risk among Obese Children.

Authors:  Yan-Ting Chen; Hui-Hsuan Wang; Ping-Yen Liu
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

5.  Radial Glia Cells Control Angiogenesis in the Developing Cerebral Cortex Through TGF-β1 Signaling.

Authors:  Michele Siqueira; Daniel Francis; Diego Gisbert; Flávia Carvalho Alcantara Gomes; Joice Stipursky
Journal:  Mol Neurobiol       Date:  2017-05-18       Impact factor: 5.590

6.  Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.

Authors:  Luis Perea; Mar Coll; Lucia Sanjurjo; Delia Blaya; Adil El Taghdouini; Daniel Rodrigo-Torres; José Altamirano; Isabel Graupera; Beatriz Aguilar-Bravo; Marta Llopis; Julia Vallverdú; Joan Caballeria; Leo A van Grunsven; Maria-Rosa Sarrias; Pere Ginès; Pau Sancho-Bru
Journal:  Hepatology       Date:  2017-07-18       Impact factor: 17.425

7.  The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2.

Authors:  Antonio Inforzato; Clair Baldock; Thomas A Jowitt; David F Holmes; Ragnar Lindstedt; Marcella Marcellini; Vincenzo Rivieccio; David C Briggs; Karl E Kadler; Antonio Verdoliva; Barbara Bottazzi; Alberto Mantovani; Giovanni Salvatori; Anthony J Day
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

8.  The Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Byung-Ju Shim; Hui-Kyung Jeon; Seung-Jae Lee; Sung-Sik Kim; Mi-Youn Park; Dong-Hyeun Lee; Woo-Seung Shin; Jong-Min Lee; Ho-Joong Youn; Wook-Sung Chung; Ki-Bae Seung
Journal:  Korean Circ J       Date:  2010-07-26       Impact factor: 3.243

Review 9.  Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Authors:  Marijn M Speeckaert; Reinhart Speeckaert; Juan J Carrero; Raymond Vanholder; Joris R Delanghe
Journal:  J Clin Immunol       Date:  2013-02-27       Impact factor: 8.317

10.  Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).

Authors:  Masato Yoneda; Takashi Uchiyama; Shingo Kato; Hiroki Endo; Koji Fujita; Kyoko Yoneda; Hironori Mawatari; Hiroshi Iida; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Shiro Maeyama; Mina Sagara; Hiroyuki Aburatani; Tatsuhiko Kodama; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2008-11-14       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.